Study of AERAS-402 in Healthy Infants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

487

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2014

Study Completion Date

April 30, 2014

Conditions
Tuberculosis
Interventions
BIOLOGICAL

AERAS-402 1.5 x 10^10 vp

BIOLOGICAL

AERAS-402 3.0 x 10^10 vp

BIOLOGICAL

AERAS-402 1.0 x 10^11 vp

BIOLOGICAL

Placebo

Trial Locations (7)

1864

Perinatal HIV Research Unit (PHRU) Chris Hani Baragwanath Hospital, Soweto

1929

CISM: Centro de Investigacao em Saude de Manhica, Manhiça

6850

SATVI: Worcester, Worcester

7925

Univeristy of Cape Town, Cape Town

40100

KEMRI/CDC Research and Public Heath Collaboration, Kisumu

Unknown

Boro Heath Center, Boro

Siaya District Hospital, Siaya

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

European and Developing Countries Clinical Trials Partnership (EDCTP)

OTHER_GOV

lead

Aeras

OTHER

NCT01198366 - Study of AERAS-402 in Healthy Infants | Biotech Hunter | Biotech Hunter